Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
pancreate cancer
Biotech
Fortress joins KRAS race through Columbia University deal
Fortress has set up a new biotech, Oncogenuity, to advance the preclinical asset and work to generate more oligonucleotides from the platform.
Nick Paul Taylor
May 8, 2020 8:45am
Five Prime taps Genentech vet Civik to take the helm
Apr 14, 2020 10:15am
BioNTech snaps up MabVax asset, labs, eyeing San Diego R&D site
May 8, 2019 9:35am
New Year biotech IPO hopefuls gun for $369M
Jan 2, 2018 4:56am
CRUK, NCI fund Ras inhibitor tests, create commercial path
Apr 19, 2017 3:21am